Hong Kong stocks recovered from a weak open; the Hang Seng Index and Hang Seng Tech Index turned positive. Innovative drug stocks led gains: Yunding Xinyao (01952.HK) rose over 7%, CSPC PHARMA (01093.HK) and Jiangsu Hengrui Medicine (01276.HK) rose over 6%.

IDC says 1H 2026 global humanoid-robot shipments approached 25,000 units, up 432.1% YoY, as the industry moves from technology validation toward commercial deployment. China accounted for over 19,000 units, roughly 77.9% of the market, with AGIBOT shipments exceeding 8,600. IDC forecasts global shipments will top 750,000 units by 2030, indicating an accelerated shift to scale applications.

Poland plans to issue foreign-currency bonds in 2027 at a scale similar to 2026.